FindTrial
Sign In

Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients

Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients - Study on the effectiveness of the combination of cepharanthin and salagen for Sjogren's syndrome patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019242
Enrollment
10
Registered
2015-10-06
Start date
2015-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren&#39

Interventions

cepharanthin, salagen

Sponsors

Department of Oral Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Primary Sjogren's syndrome

Exclusion criteria

Exclusion criteria: Secondary Sjogren's syndrome, Xerostomia due to aging

Design outcomes

Primary

MeasureTime frame
Improvement of infiltration of lymphocytes—

Secondary

MeasureTime frame
Increase in salivary flow, Improvement of CRP level—

Countries

Japan

Contacts

Public ContactKoichi Kani

Tokushima University Hospital Department of Oral Medicine

kani.koichi.1@tokushima-u.ac.jp088-633-7352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026